Lilly’s former U.S. president joins GSK
Executive Summary
Deirdre Connelly joins GlaxoSmithKline as President North American Pharmaceuticals, effective Feb. 9. CEO Andrew Witty said Connelly's track record aligns with the firm's plan to increase payer and physician focus for sales reps in the U.S. Connelly resigned from her position as head of Lilly's U.S. operations Jan. 30 (1"The Pink Sheet," Feb. 2, 2009, In Brief)
Deirdre Connelly joins GlaxoSmithKline as President North American Pharmaceuticals, effective Feb. 9. CEO Andrew Witty said Connelly's track record aligns with the firm's plan to increase payer and physician focus for sales reps in the U.S. Connelly resigned from her position as head of Lilly's U.S. operations Jan. 30 (1 'The Pink Sheet,' Feb. 2, 2009, In Brief). |